These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22477003)

  • 1. Estimating average glucose levels from glycated albumin in patients with end-stage renal disease.
    Kim JK; Park JT; Oh HJ; Yoo DE; Kim SJ; Han SH; Kang SW; Choi KH; Yoo TH
    Yonsei Med J; 2012 May; 53(3):578-86. PubMed ID: 22477003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood glucose levels in peritoneal dialysis are better reflected by HbA1c than by glycated albumin.
    Watanabe Y; Ohno Y; Inoue T; Takane H; Okada H; Suzuki H
    Adv Perit Dial; 2014; 30():75-82. PubMed ID: 25338425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.
    Mukai N; Ninomiya T; Hata J; Hirakawa Y; Ikeda F; Fukuhara M; Hotta T; Koga M; Nakamura U; Kang D; Kitazono T; Kiyohara Y
    Cardiovasc Diabetol; 2015 Jun; 14():84. PubMed ID: 26099223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of glycated albumin in serum and plasma by LC-MS/MS.
    Brede C; Hop B; Jørgensen K; Skadberg Ø
    Scand J Clin Lab Invest; 2016; 76(3):195-201. PubMed ID: 26898156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases.
    Inoue K; Goto A; Kishimoto M; Tsujimoto T; Yamamoto-Honda R; Noto H; Kajio H; Terauchi Y; Noda M
    Clin Exp Nephrol; 2015 Dec; 19(6):1179-83. PubMed ID: 25824109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA).
    Chujo K; Shima K; Tada H; Oohashi T; Minakuchi J; Kawashima S
    J Med Invest; 2006 Aug; 53(3-4):223-8. PubMed ID: 16953058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
    Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T;
    Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
    Fukuoka K; Nakao K; Morimoto H; Nakao A; Takatori Y; Arimoto K; Taki M; Wada J; Makino H
    Nephrology (Carlton); 2008 Jun; 13(4):278-83. PubMed ID: 18476915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
    Desouza CV; Rosenstock J; Zhou R; Holcomb RG; Fonseca VA
    Endocr Pract; 2015 Nov; 21(11):1195-203. PubMed ID: 26214108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct biomarker roles for HbA
    Hayashi A; Takano K; Masaki T; Yoshino S; Ogawa A; Shichiri M
    J Diabetes Complications; 2016; 30(8):1494-1499. PubMed ID: 27614726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.